Physician

Hani Shaban Alkhatib, MB, BCH

According to 2025 Medicare claims, Hani Alkhatib, MB, BCH (NPI: 1750372900) practices hematology/oncology in the St. Cloud, MN market, with the plurality of this provider's patient population coming from Stearns, MN. This provider's primary affiliated billing organization is ST. CLOUD HOSPITAL (NPI: 1043269798; TIN: 410695596) and primary practice location at 56303-5000. Alkhatib is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Alkhatib's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 3,293 HCPCS/CPT codes, and received $193,013 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,049 prescription claims across 441 beneficiaries totaling $10,516,593 in drug costs, led by Vyndamax (Tafamidis). DME data shows 36 claims. Open Payments data shows 4 records totaling $1,775. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $68,293 to $193,013. Similarly, Part D prescription costs have risen steadily, from $1,643,421 to $10,516,593. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,171 to $749.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	275	1,116	$68,293
2016	293	1,134	$72,172
2017	296	1,486	$91,340
2018	340	1,459	$94,911
2019	632	2,802	$184,568
2020	589	2,116	$128,950
2021	565	2,487	$204,299
2022	528	2,182	$174,440
2023	536	2,227	$175,139
2024	526	3,293	$193,013

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	250	1,935	$1,643,421
2016	298	2,288	$3,618,591
2017	345	2,627	$3,809,599
2018	379	2,860	$3,844,791
2019	358	3,027	$4,934,439
2020	331	2,208	$4,165,914
2021	362	2,701	$5,916,353
2022	335	2,421	$5,842,583
2023	358	2,695	$5,707,227
2024	441	3,049	$10,516,593

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	179	$52,708
2016	N/R	154	$12,708
2017	12	93	$13,710
2018	N/R	85	$12,004
2019	59	301	$47,270
2020	11	155	$9,873
2021	N/R	148	$7,296
2022	11	114	$7,810
2023	12	114	$8,257
2024	N/R	36	$907

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	65	66	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	170	368	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	386	1,447	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	69	79	$37
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	352	984	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	151	4,530	$3,260,774
Brukinsa	Zanubrutinib	121	3,630	$1,758,841
Revlimid	Lenalidomide	45	1,197	$799,590
Vyndaqel	Tafamidis Meglumine	27	810	$568,967
Jakafi	Ruxolitinib Phosphate	22	645	$515,249

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8530	Cyclophosphamide; oral, 25 mg	N	N/R	18	$587
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$320

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$1,775	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hani Shaban Alkhatib, MB, BCH?

Tedicare shows public-source Medicare data for Hani Shaban Alkhatib, MB, BCH (NPI 1750372900), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hani Shaban Alkhatib, MB, BCH have ACO affiliation data?

Hani Shaban Alkhatib, MB, BCH is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Hani Shaban Alkhatib, MB, BCH?

Hani Shaban Alkhatib, MB, BCH is linked to ST. CLOUD HOSPITAL (billing NPI 1043269798) in the available physician profile data.

Does Hani Shaban Alkhatib, MB, BCH have Open Payments data?

Hani Shaban Alkhatib, MB, BCH has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.